Activity 1: Assist WHO globally in advocating and facilitating countries on universal health coverage to improve financial protection
Universal
health care coverage (UHC) is widely accepted as one of key goals of health system
and policy. Many low- and middle-income countries (LMICs) of Asia are struggling
toward UHC, but they should overcome various barriers in health systems. Korea
achieved universal health coverage in a relatively short time period, and the
process of achieving UHC can provide valuable lessons (both positive and
negative) to LMICs in the WHO Member States.
The
collaborating centre works with WHO in providing advocacy and technical
support to the Member States in their efforts to achieve UHC with an emphasis
on financial protection. The technical areas cover the revenue collection,
pooling and purchasing, priority setting, service delivery, pharmaceutical
policy, etc. The activities include development of case studies, scoping
papers, and policy briefs on health financing, resource allocation and priority
setting, pharmaceuticals, hospital reform, and ageing and long-term care; and
collaboration on UHC Forum. -
Technical support to WHO Member States in developing their national health
insurance system and health financing policy
- Policy
briefing and recommendation note responding to the needs of specific LMICs Pharmaceuticals and technology are a major component of health
system and increasing equitable access to essential medicines and health technologies
is a key corner stone of efforts directed at moving toward UHC. Expenditure on
medicines often causes catastrophic health expenditure and often accounts for significant
portion of overall healthcare costs. National pharmaceutical policy needs to
adopt a health system perspective, beyond its emphasis on safety, quality and
efficacy issues and link clearly with health system financing policies to achieve
most efficient use. Demand for long-term care with population ageing and
hospital reforms in LMICs also became important issues that should be addressed
in the future.
The centre serves as a platform for experts and policy
makers in the region to discuss key policy issues and generate evidence-based
policy recommendations for pharmaceuticals with regard to selection, financing
and use medicines and health technologies to achieve optimal outcomes with limited
resources available to health systems. With
WHO, the centre provides support for ‘Access to Medicines Network’, including
annual meeting, and works on the generation and dissemination of pharmaceutical
policy on medicine pricing and reimbursement.
Expected deliverables:
- Consultancy reports on key topics of UHC
- Host study visits of policy makers from LMICs
Activity 2: In agreement with WHO, provide training courses for capacity building for policy makers and researchers on health care financing, health policy, health economics, and pharmaceutical policy in the region
The capacity in developing
evidence-based policy is critical for sustainable development
of health system for UHC. Taking the advantage of faculty in the university, training workshops for multi-countries and individual countries have been organized. The topics cover broader health system and health financing
areas, but are tailored to countries’ need. The audience of the training
are government officials as well as policy researchers in universities and
academic institutions. Apart from training courses, the centre provides hand-on technical support to country team on specific technical topics. The centre also provides support to WHO in developing country capacity in health financing
and health systems, including collaboration on the annual WHO Bi-regional
Workshop on Health Financing Policy for UHC.
Expected deliverables:
- Organize training courses on
health financing, health insurance
- Technical support to country teams in policy research in the area of health
financing, health policy, health economics, long-term care, and pharmaceutical
policy in the region
Activity 3: Work with WHO globally in the generation and dissemination of knowledge and information on universal health coverage and health systems, including health financing, ageing and long-term care, pharmaceuticals, and hospital reforms
Expected deliverables:
- Series of reports on key
policy issues of pharmaceutical policy, technical papers and guideline for pharmaceutical
policy
- Participation and support to regional knowledge hub/collaborations that can facilitate
sharing of experiences and mutual learning between national policy and decision
and contribute to capacity development
Funding sources:
The Centre works on various projects funded by MoHW (Ministry of Health and Welfare), KOICA (Korea International Cooperation Agency), KoFIH (Korea Foundation for International Health), NHIS (National Health Insurance Service), HIRA (Health Insurance Review and Assessment) in addition to international organizations.